Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05539443 · ClinicalTrials.gov registry record · NA
Telehealth-Enhanced Assessment and Management After Stroke-Blood Pressure
A NA study of Hypertension Secondary, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT05539443: Completed NA study of Hypertension Secondary, sponsored by Wake Forest University Health Sciences.
NCT05539443 is a NA study of Hypertension Secondary that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05539443, a NA study of Hypertension Secondary, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
TEAMS-BP is a multicenter, participant-randomized controlled trial designed to compare the effectiveness of Intensive Tailored Telehealth Monitoring (ITTM) versus Intensive Clinic Management (ICM) on Blood Pressure (BP) control and patient activation for BP management following stroke
Conditions Studied
Interventions
- BEHAVIORAL Intensive Clinic Management (ICM)
- BEHAVIORAL Intensive tailored telehealth management (ITTM)
Study Locations (1)
North Carolina
- Atrium Health Wake Forest Baptist - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
What the finished NCT05539443 record still lists
NCT05539443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Hypertension Secondary appearing as the primary indexed condition, and to 2 interventions - of which Intensive Clinic Management (ICM) is the first listed.
NCT05539443 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05539443 about?
NCT05539443 is a clinical study titled "Telehealth-Enhanced Assessment and Management After Stroke-Blood Pressure". TEAMS-BP is a multicenter, participant-randomized controlled trial designed to compare the effectiveness of Intensive Tailored Telehealth Monitoring (ITTM) versus Intensive Clinic Management (ICM) on Blood Pressure (BP) control and patient activation for BP management following stroke
What is the current status of trial NCT05539443?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2022-10-11. Estimated completion is 2023-09-30.
What conditions does trial NCT05539443 study?
This clinical trial studies the following conditions: Hypertension Secondary.
What interventions are being tested in trial NCT05539443?
The interventions under investigation include: Intensive Clinic Management (ICM) (BEHAVIORAL), Intensive tailored telehealth management (ITTM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05539443?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05539443 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05539443's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI